4
Changes in Ownership
Insight Molecular Diagnostics Inc. Filed Acc 0001493152-22-035089
Former CEO acquired 250,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ANDREWS RONALD ASBURY Former CEO | 2022-12-01 | Option exercise | +250,000 | 583,212 | D | ||
| Derivatives | |||||||
| ANDREWS RONALD ASBURY Former CEO | 2022-12-01 | Returned to the company · Option to Purchase Common Stock | −20,000 | 0 | D | ||
| ANDREWS RONALD ASBURY Former CEO | 2022-12-01 | Returned to the company · Option to Purchase Common Stock | −45,000 | 0 | D | ||
| ANDREWS RONALD ASBURY Former CEO | 2022-12-01 | Returned to the company · Option to Purchase Common Stock | −950,000 | 0 | D | ||
| ANDREWS RONALD ASBURY Former CEO | 2022-12-01 | Returned to the company · Option to Purchase Common Stock | −50,000 | 0 | D | ||
| ANDREWS RONALD ASBURY Former CEO | 2022-12-01 | Returned to the company · Option to Purchase Common Stock | −500,000 | 0 | D | ||
| ANDREWS RONALD ASBURY Former CEO | 2022-12-01 | Returned to the company · Option to Purchase Common Stock | −300,000 | 0 | D | ||
| ANDREWS RONALD ASBURY Former CEO | 2022-12-01 | Returned to the company · Option to Purchase Common Stock | −93,750 | 281,250 | D | ||
| ANDREWS RONALD ASBURY Former CEO | 2022-12-01 | Returned to the company · Restricted Stock Units | −35,000 | 0 | D | ||
| ANDREWS RONALD ASBURY Former CEO | 2022-12-01 | Returned to the company · Restricted Stock Units | −250,000 | 250,000 | D | ||
| ANDREWS RONALD ASBURY Former CEO | 2022-12-01 | Option exercise · Restricted Stock Units | −250,000 | 0 | D | ||
| ANDREWS RONALD ASBURY Former CEO | 2022-12-07 | Grant or award · Option to Purchase Common Stock | +50,000 | 50,000 | D | ||
Loading xslF345X03/ownership.xml…